Paolo Fundaro is Director & 10% Owner at INTERCEPT PHARMACEUTICALS, INC. (ICPT). They have made 3 open-market trades across 1 company since 2013, most recently 2023-11-08.
CIK 0001559537
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ICPT | 43,905 | $834K |
Shares reported on the most recent Form 4, priced at the 2023-05-25 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ICPT | SELL | 2020-08-13 | 2020-08-17 | $47.71 | $77.6M | +3.5% | -6.3% | -20.4% |
| ICPT | SELL | 2020-05-13 | 2020-05-15 | $84.60 | $100.8M | -15.8% | -10.4% | -40.0% |
| ICPT | SELL | 2019-03-29 | 2019-03-29 | $107.45 | $467K | +6.8% | -21.8% | -29.7% |
| ICPT | SELL · 10b5-1 | 2015-07-24 | 2015-07-24 | $285.00 | $166K | -17.1% | +1.2% | +1.2% |
| ICPT | SELL · 10b5-1 | 2014-08-11 | 2014-08-12 | $239.49 | $78K | -17.1% | +1.2% | +1.2% |
| ICPT | SELL · 10b5-1 | 2014-05-09 | 2014-05-09 | $232.00 | $75K | -17.1% | +1.2% | +1.2% |
| ICPT | SELL · 10b5-1 | 2014-02-12 | 2014-02-14 | $375.26 | $2.7M | -17.1% | +1.2% | +1.2% |
| ICPT | SELL · 10b5-1 | 2013-08-12 | 2013-08-13 | $46.13 | $220K | -17.1% | +1.2% | +1.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.